The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

In a small Phase II trial in China, the drug triggered an average 15.1% weight loss over 12 weeks. Novo Nordisk now hopes to conduct a global Phase I/II trial to fast-track the drug to the global ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Key Takeaways The number of people taking GLP-1 drugs to lose weight more than tripled in recent yearsThe percentage of ...

The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

Several studies have been done on the myriad list of side effects that come from popular weight loss drugs. A new study conducted ... own analysis before making any investment based on your ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

This might have been easy for a billionaire like Winfrey to say. Weight-loss drugs can be game-changing for people who are obese, but getting hold of them is far from a level playing field ...

But there are many questions left to answer, not least what the future holds for weight-loss medications and society at large ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those taking popular weight loss medications containing semaglutide ...

Amy Schumer revealed she’s on a new weight loss medication after her last attempt on the drugs left her so nauseous she couldn’t lift her head off the pillow. “Mounjaro’s been great ...